Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$203.52 - $273.43 $447,744 - $601,546
-2,200 Reduced 17.19%
10,600 $2.87 Billion
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $2.11 Million - $3.06 Million
12,800 New
12,800 $3.03 Billion

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.32B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Susquehanna Portfolio Strategies, LLC Portfolio

Follow Susquehanna Portfolio Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Portfolio Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Portfolio Strategies, LLC with notifications on news.